Las Vegas DePuy Hip Implant Attorneys
Shook & Stone is committed to achieving results for our clients
Having surgery, especially for a hip replacement, presents many challenges
for a person in terms of recovery and rehabilitation. Because patients
trust that medical device manufacturers have properly tested and designed
their products, ensuring they are effective and safe, most people don’t
think twice about the quality or condition of the device being used for
their knee, or hip replacement. However, as the infamous DePuy hip implant
device recall demonstrates, this trust has the potential to be broken.
DePuy Hip Replacement Recall
DePuy Orthopaedics, Inc., a Johnson & Johnson subsidiary, announced
a voluntary recall of its ASR™ XL Acetabular Systems and DePuy ASR™
Hip Resurfacing Systems after receiving reports that many patients needed
corrective, secondary surgery to replace their hip implant device due
to failure. The National Joint Registry (NJR) of England and Wales supplied
data from 2010 that reflected a five-year revision rate of approximately
12 percent for the ASR™ Hip Resurfacing System and approximately
13 percent for the ASR™ XL Acetabular System.
Introduced in 2003, the DePuy ASR™ Hip Resurfacing System was only
been approved for use outside the United States. On the other hand, the
ASR™ XL Acetabular System was launched in 2004 and was distributed
worldwide. The ASR device was preferred by orthopedic surgeons for young
patients who were thought to benefit the most from the stability of the
device, therefore lowering the odds of problems with dislocation.
Hip Implant Complications
The need for revision hip surgery in patients with affected DePuy implants
stems from complications such as hip system failure, hip implant device
becoming loose, excessive hip pain or discomfort, weakness, and swelling.
Some of the most serious side effects of the DePuy hip implant devices
include tumors around the implant as well as metal fragments from the
implant entering the bloodstream and causing an increased risk of blood
clots and heavy metal poisoning.
Signs of inefficiency
The U.S. Food and Drug Administration (FDA) noted about 400 complaints
from patients in 2008 in regards to
catastrophic injuries do to the failure of DePuy hip replacement devices. It was at this time
that a 13 percent revision surgery rate was reported, a rate significantly
greater than most hip replacements. Nevertheless, it wasn’t until
2009 that DePuy removed the ASR hip systems from the market in Australia.
The devices continued to be sold in the U.S. until the end of 2010.
Fighting Back: Legal Experience Committed to You
Orthopedics is not only a necessary branch of medicine; it’s also
a billion dollar industry. There are instances when a person experiences
extreme arthritic pain or suffers an injury and there’s no way of
avoiding hip replacement surgery. A person doesn’t just bounce back
from this type of procedure; it takes weeks, if not months, before they
can return to normal in regaining strength and mobility.
While some discomfort is to be expected from hip replacement surgery, if
you have suffered serious side effects or experienced complications, you
should consult with your doctor to see if revision hip implant surgery
is necessary. You may also wish to speak with a
Las Vegas personal injury lawyer who has experience protecting the rights of individuals harmed by defective
medical devices and implant systems.
At Shook & Stone, our Nevada
defective product lawyers are committed to ensuring the best possible outcome for our clients. We
have the resources and skills to build strong, effective cases so that
negligent manufacturers don’t get off the hook for acts of oversight
and negligence. To learn more about how we can help, call (888) 662-2013
for a free consultation.